Cornercap Investment Counsel Inc Tcr2 Therapeutics Inc. Transaction History

Cornercap Investment Counsel Inc

  • $329 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$1.0 - $1.62 $3,011 - $4,877
3,011 Added 4.43%
71,046 $106,000
Q3 2022

Nov 14, 2022
BUY
$1.86 - $3.75 $38,284 - $77,186
20,583 Added 43.38%
68,035 $122,000
Q2 2022

Aug 15, 2022
BUY
$2.11 - $2.94 $100,123 - $139,508
47,452 New
47,452 $138,000

About TCR2 THERAPEUTICS INC.

TCRR Quotes by TradingView
  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email